DRUG

5-NBA

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for 5-NBA

ALS 3

Mediator Outcome Score Tier Lit. status Trial
α-synuclein Parkinson's disease 0.220 Mid partial evidence none
α-synuclein multiple system atrophy 0.220 Mid novel signal none
α-synuclein neurodegenerative diseases 0.220 Mid novel signal none

Clinical trials

1 registered trial for 5-NBA

Source: ClinicalTrials.gov